HEMOSTATIC PREPARATION

FIELD: medicine, experimental medicine. ^ SUBSTANCE: for the purpose to stop hemorrhages it is necessary to introduce fibrin-monomer for a rabbit at the dosages ranged 0.5-5 mg/kg animal body weight. In case of intravenous injection at the dosages ranged 0.5-5 mg/kg animal body weight fibrin-monomer...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MOMOT ANDREJ PAVLOVICH, SOKOLOV EHDUARD ANATOL'EVICH, MAKAROV VLADIMIR ALEKSANDROVICH, TER-ARUTJUNJANTS ARTEM ANDREEVICH, BELOZERSKAJA GALINA GENNAD'EVNA, VASIL'EVA TAT'JANA MIKHAJLOVNA
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine, experimental medicine. ^ SUBSTANCE: for the purpose to stop hemorrhages it is necessary to introduce fibrin-monomer for a rabbit at the dosages ranged 0.5-5 mg/kg animal body weight. In case of intravenous injection at the dosages ranged 0.5-5 mg/kg animal body weight fibrin-monomer is of immediate hemostatic action and has no influence upon basic hemostatic parameters. ^ EFFECT: higher efficiency. ^ 5 ex